Valuation: Hikma Pharmaceuticals PLC

Market Cap 4.49B 4.02B 3.71B 3.37B 6.37B 421B 6.55B 44.4B 17.69B 225B 16.84B 16.48B 712B P/E 2026 *
11.6x
P/E 2027 * 10.6x
Enterprise Value 5.99B 5.37B 4.95B 4.5B 8.51B 562B 8.75B 59.3B 23.63B 301B 22.49B 22.01B 952B EV / Sales 2026 *
1.74x
EV / Sales 2027 * 1.63x
Free-Float
63.7%
Yield 2026 *
4.03%
Yield 2027 * 4.21%
1 week-6.77%
Current month-6.12%
1 month+0.81%
3 months-1.46%
6 months+14.64%
Current year+4.84%
1 week 1,611
Extreme 1611
1,750
1 month 1,569
Extreme 1569
1,762
Current year 1,187
Extreme 1187
1,762
1 year 1,187
Extreme 1187
1,762
3 years 1,187
Extreme 1187
2,360
5 years 1,174.5
Extreme 1174.5
2,387
10 years 814.2
Extreme 814.2
2,768
Manager TitleAgeSince
Chief Executive Officer 69 01/12/2025
Director of Finance/CFO - 26/02/2026
Chief Tech/Sci/R&D Officer 64 26/02/2026
Director TitleAgeSince
Director/Board Member 69 14/10/2005
Director/Board Member 54 15/12/2025
Chairman 69 15/05/2014
Date Insider Type Main position Quantity % Market Cap. Importance
1/6/26 Sell

Investor Relations Manager

-26,558 0.0124%
1/6/26 Exercice

Director

72,763 0.0339%
1/6/26 Exercice

Director

20,650 0.0096%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-6.77%+4.50%-7.28% 4.49B
+1.44%+1.63%+48.17%+139.63% 1,276B
-0.47%+5.49%+49.03%+90.68% 676B
+0.20%+2.76%+34.37%+112.06% 519B
+0.17%+2.76%+44.07%+69.71% 388B
-0.48%+2.34%+70.66%+46.02% 365B
+0.76%+2.27%+31.59%+60.36% 307B
-1.29%+0.90%+5.77%+37.60% 287B
0.00%+0.86%+43.74%+74.04% 252B
+0.92%+2.03%+44.62%+125.07% 212B
Average -0.03%+1.43%+37.65%+74.79% 429B
Weighted average by Cap. -0.09%+2.50%+43.67%+97.03%

Financials

2026 *2027 *
Net sales 3.45B 3.1B 2.85B 2.59B 4.9B 324B 5.04B 34.16B 13.61B 173B 12.96B 12.68B 548B 3.57B 3.2B 2.95B 2.68B 5.07B 335B 5.21B 35.34B 14.08B 179B 13.4B 13.12B 567B
Net income 415M 373M 343M 312M 590M 38.95B 607M 4.11B 1.64B 20.87B 1.56B 1.53B 65.96B 447M 401M 370M 336M 635M 41.93B 653M 4.43B 1.76B 22.46B 1.68B 1.64B 71.01B
Net Debt 1.51B 1.35B 1.24B 1.13B 2.14B 141B 2.2B 14.9B 5.94B 75.63B 5.65B 5.53B 239B 1.32B 1.18B 1.09B 991M 1.88B 124B 1.93B 13.07B 5.21B 66.32B 4.95B 4.85B 210B
Projected Income Statement - Annual - Hikma Pharmaceuticals PLC
Logo Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC is a multinational pharmaceutical company engaged in the development, manufacturing and marketing of a broad range of generic, branded and specialty pharmaceutical products. Its pharmaceutical operations are conducted through three business segments: Injectables, Branded and Hikma Rx. It supplies hospitals across North America, Europe and the Middle East and North Africa (MENA) region with generic injectable and specialty medicines, supported by its growing global manufacturing network. It supplies branded generic and in-licensed products from its local manufacturing facilities to retail and hospital customers across the MENA region. Through Hikma Rx, it supplies oral, respiratory and other generic and specialty products to the North American market. Its manufacturing facilities in the United States (US) supply products across a broad range of therapeutic areas, including respiratory, oncology and pain management, serving customers in both the US and Canada.
Employees
9,500
Date Price Change Volume
10/11/26 GBX 1,625.00 0.00% 664,194
09/11/26 GBX 1,625.00 -1.52% 1,525,837
06/11/26 GBX 1,650.00 -2.77% 817,940
05/11/26 GBX 1,697.00 -3.69% 822,670
04/11/26 GBX 1,762.00 +1.09% 736,955
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Hikma Pharmaceuticals PLC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
21.65USD
Average target price
26.61USD
Spread / Average Target
+22.92%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Hikma Pharmaceuticals PLC